3-Acetyl-4-(4-ethylpiperazin-1-yl)-7-((5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyrimidin-2-yl)amino)-2H-chromen-2-one

ID: ALA4779614

PubChem CID: 162662953

Max Phase: Preclinical

Molecular Formula: C28H27F2N5O4

Molecular Weight: 535.55

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN1CCN(c2c(C(C)=O)c(=O)oc3cc(Nc4ncc(F)c(-c5ccc(F)cc5OC)n4)ccc23)CC1

Standard InChI:  InChI=1S/C28H27F2N5O4/c1-4-34-9-11-35(12-10-34)26-20-8-6-18(14-23(20)39-27(37)24(26)16(2)36)32-28-31-15-21(30)25(33-28)19-7-5-17(29)13-22(19)38-3/h5-8,13-15H,4,9-12H2,1-3H3,(H,31,32,33)

Standard InChI Key:  FENPXPBUKNHHHM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   10.5478  -20.2935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5466  -21.1131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2547  -21.5220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9643  -21.1126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9615  -20.2899    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2529  -19.8847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2545  -22.3392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5469  -22.7449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5464  -23.5613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2545  -23.9709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9647  -23.5581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9617  -22.7430    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6737  -23.9644    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3801  -23.5534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0859  -23.9606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0755  -22.3262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3725  -22.7388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7895  -22.7323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7875  -23.5545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4945  -23.9651    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2082  -23.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2103  -22.7358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4986  -22.3207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4995  -21.5035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.9143  -23.9693    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2138  -21.0967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2167  -20.2831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5112  -19.8699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8013  -20.2765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7967  -21.0962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6767  -21.5202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3828  -21.1089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9194  -22.3297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6257  -22.7408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9223  -21.5125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.2556  -19.0661    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.8418  -22.3331    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.5152  -19.0527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2249  -18.6475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 19  1  0
 18 16  1  0
 16 17  2  0
 17 14  1  0
 18 19  2  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 21 25  2  0
 24 26  1  0
 24 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
  4 31  1  0
 31 32  1  0
 22 33  1  0
 33 34  1  0
 33 35  2  0
  6 36  1  0
  8 37  1  0
 28 38  1  0
 38 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4779614

    ---

Associated Targets(Human)

CCNT1 Tchem CDK9/cyclin T1 (2643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem CDK2/Cyclin A2 (2260 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 535.55Molecular Weight (Monoisotopic): 535.2031AlogP: 4.62#Rotatable Bonds: 7
Polar Surface Area: 100.80Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.97CX Basic pKa: 6.79CX LogP: 3.69CX LogD: 3.59
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.27Np Likeness Score: -1.11

References

1. Xu J,Li H,Wang X,Huang J,Li S,Liu C,Dong R,Zhu G,Duan C,Jiang F,Zhang Y,Zhu Y,Zhang T,Chen Y,Tang W,Lu T.  (2020)  Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity.,  200  [PMID:32447197] [10.1016/j.ejmech.2020.112424]

Source